Furthermore, higher expression of ANO1 was observed in cancer tissue compared with normal counterpart tissue in gastric carcinomas [9], hepatocellular carcinoma [10], and prostatic carcinomas [11]. This evidence concerns the gene ANO1 and hepatocellular carcinoma.